Improving Maternal and Child Health Through Prenatal Fatty Acid Supplementation
Running, not enrolling · Not applicable
Conditions studied: Pregnancy, Child Development
In brief
The purpose of the study is to test whether nutritional supplementation during pregnancy is associated with 1) improved maternal health during pregnancy; 2) improved infant birth and neurodevelopmental outcomes, and 3) whether the association between nutritional supplementation during pregnancy and infant outcomes is partially mediated by reductions in maternal perceived stress and stress reactivity during pregnancy.
Key facts
- Study ID
- NCT02647723
- Run by
- University of Chicago
- People needed
- 168
- Starts
- 2016-01-01
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-07-17
Who can join
Age: 18 and older, up to 34. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Age between 18 and 34
- Household recipient of public assistance (e.g. Medicaid insurance) due to low income
- Low levels of DHA consumption as defined as less than two fish servings per week
You may not qualify if…
- Reports of known medial complications
- Regular use of steroid medications, alcohol, cigarettes, or illegal substances (by maternal report)
- Use of blood thinners or anti-coagulants
- Use of psychotropic medications
- Allergy to iodine and/or soy
Where it is running
- University of Chicago Medicine — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.